The best feedback we can receive from a #radonc resident: "My ACR In-Service Exam Score this year improved DRASTICALLY using this QBank to study. It has also helped me feel more confident and knowledgeable in clinic and tumor boards.
Calling all #radonc residents, especially PGY-5s!
Want oral boards practice but can't find your own group?
We are forming #oralboards study groups to take the stress out of you finding one yourself!
⬇
https://t.co/J2fstvqJrS
The next @RadoncROVER session on radiopharmaceuticals is taking place March 1 at 12 pm PST. The speakers for this session include ACRO member Dr. @brandonmancini, and Drs. Kristin Plichta and Ravi Patel. Register here: https://t.co/j13DHROnLm
I religiously listened to @d_golden’s intro to #RadOnc lectures as a medical student. And now, I know beyond a talented educator, he is an awesome and extremely kind individual. @DoctorNoMD, @ARRO_org, and I are honored to collaborate with you! @AtTheBeam
📣Hey Radiation Oncology residency applicants, meet our local Program Directors! Featured here is Dr. Dan Golden: Rad Onc PD at Rush University Medical Center, medical education expert, ROECSG chair, and one of our featured CRS speakers this year!
Learn more on this thread!
Congratulations to @KenOlivierMD & Nicholas Remmes, PhD for being honored by the @MayoClinic Academy of Education!
Dr. Olivier was honored as a Legacy Member for his dedication to education at Mayo & nationally.
Dr. Remmes earned the distinction of an Associate Member!
@Rubab_Aftab@ARRO_org@ACROresident@RadOncPDs Unfortunately, no. Sorry! For tax purposes this is limited to residents in the United States. We do accept international ad hoc editors. Please email us if you’re interested.
📢
@RadOncQuestions is seeking 4 motivated #RadOnc residents to join our team for 1 year terms as Resident Editors in 1/2024. Applications will be accepted until 12/23/2023. Details are in the following thread: (1/3)
@ARRO_org@ACROresident@RadOncPDs
https://t.co/69h9qIpzWV
If interested, please send the following to support @ https://t.co/9plAR5semV:
- Current CV
- Brief personal statement (less than a half page)
- Prior in-service score reports
https://t.co/xBzackSWjf
(3/3)
Resident editors get a free 1-yr subscription (or prorated reimb), $500 honorarium to review content, earn up to $1000 for writing new questions, and can earn add'l $ for responding to comments. Applicants must be current PGY4s in an ACGME-accredited #RadOnc residency in the USA
Sign up now for the eContouring for Breast Cancer webinar led by Dr. @MylinTorres. #RadOnc residents can register FREE of charge with support from the ROI Juan A. del Regato Fund at https://t.co/fFPSJRmPSc. Must be an @ASTRO_org member-in-training for free registration @ARRO_org
Just published @IJROBP!! ChatGPT has its uses, but NOT as a tool for answering medical questions. In this study, we posed 100s of rad onc questions to chatGPT that a patient or physician would ask. It did not do well... https://t.co/UNnsRxbg54
🚨🚨🚨 #Radonc
Interested in learning more about:
🔵 Neoadjuvant tx for pancreas cancer, 11/1, 12 CST
🔵 Tx of extrahepatic biliary cancer
🔵 Non-surgical tx of liver metastasis
🔥Register here (FREE) for upcoming webinars led by the ARS GI committee!
https://t.co/il3fEKpwxH
What do patients with esophagus cancer value?
In this study (n=100), patients were willing to accept a 16% decrement in 5-year OS for an opportunity to undergo an active surveillance regimen after neoadjuvant chemoRT.
Therefore, with SANO showing similar OS and better QOL with organ preservation (deets/confirmation pending presentation in a few days), active surveillance should be A standard of care for patients with esophagus cancer achieving a complete response to chemoRT.
https://t.co/09Opxuqmuy
@OncoAlert
In the multiverse battle of Surgery x SBRT, lung 🫁 cancer always ends up losing. Such an awesome human being. Amazing thoracic surgeon 👨🏽⚕️ . Good to have people like you around to look up to. Thanks for your friendship @ruyfkcs!
#GBOT2023#LungCancer#RadOnc
Critical patient care issues should be spared of the pervasive culture of misleading click bait.
Proud that Drs. Shaverdian /@reshmajagsi for raising awareness.
@ASTRO_org@MSK_RadOnc@SameerKeoleMD@RadOncWomen
When Headlines Harm Patients With Cancer https://t.co/1Lp4Hxb2O3